SCHEMBL6429396

SCHEMBL6429396

c1cc2c3ccccc3cc-2c2ccncc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKE Q14164 1/20 0.56
▸ TBK1 Q9UHD2 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.52
▸ LMNA P02545 1/20 0.52
▸ CYP1A2 P05177 1/20 0.52
▸ CYP3A4 P08684 1/20 0.52
▸ CYP2D6 P10635 1/20 0.52
▸ CYP2C9 P11712 1/20 0.52
▸ CYP2C19 P33261 1/20 0.52
▸ MAPKAPK2 P49137 1/20 0.52
▸ KDR P35968 9/20 0.50
▸ CYP11B1 P15538 1/20 0.50
▸ HTT P42858 2/20 0.47
▸ TNF P01375 1/20 0.47
▸ SLC22A12 Q96S37 1/20 0.46
▸ ADRA2A P08913 1/20 0.45
▸ ADRA2B P18089 1/20 0.45
▸ ADRA2C P18825 1/20 0.45
▸ ADRA1A P35348 1/20 0.45
▸ ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6240424 0.88 LMNA (0.63) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL5231404 0.87 TNF (0.64) IKBKETBK1KDM4ELMNACYP11B1
SCHEMBL24621795 0.83 IKBKE (0.54) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL13320306 0.81 CYP11B1 (0.59) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL14639947 0.80 IKBKE (0.48) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL23347094 0.80 IKBKE (0.48) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL4037425 0.80 ALDH1A1 (0.58) KDM4ECYP1A2CYP3A4ALDH1A1HPGD
SCHEMBL6998015 0.79 TNF (0.73) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL1102876 0.77 CYP11B1 (0.50) IKBKETBK1KDM4ELMNACYP1A2
SCHEMBL22454006 0.77 KDR (0.49) IKBKETBK1KDM4ELMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050130956-A1 1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof PLIVA-ISTRAZIVACKI INSTITUT D.O.O. (HR) 2005-06-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050130956-A1 1-oxa 3-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the production thereof TNF, IL1A, IL1B IKBKE 17/4885TBK1 1194/4885KDM4E 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback